RNA, U6 small nuclear 930, pseudogene (RNU6-930P)

RNA, U6 small nuclear 930, pseudogene (RNU6-930P) is classified as a **pseudogene** corresponding to the U6 small nuclear RNA (snRNA) family[1][2]. Members of the U6 snRNA family are involved in pre-mRNA splicing as components of the spliceosome; however, as a pseudogene, RNU6-930P does not encode a functional product and is *not involved in protein-coding or functional RNA activity*[1][2]. RNU6-930P is thus not considered a therapeutic target, nor is it implicated in disease or drug response. **Justification and context:** - RNU6-930P is explicitly annotated as a "pseudogene," and pseudogenes by definition do not produce functional proteins or functional RNA products and are generally transcriptionally inactive or nonfunctional[1][2][5]. - Aliases such as RNU6-1173P reflect other similar pseudogene entries for U6 snRNA variants[2]. - No biological, pharmacological, or disease function is attributed to this entry in curated databases; no literature associates it with a therapeutic target, biomarker function, or drug interaction[1][2][5]. - The underlying functional U6 snRNA family is mechanistically essential in spliceosomal activity, but this pseudogene form has **no such role**[3][4]. **Summary:** This entry is for a nonfunctional pseudogene, *not* a therapeutic target or relevant biomarker, and all functional, mechanistic, or drug-related fields should be returned as null or empty.

Other names

RNU6-1173PRNA, U6 small nuclear 1173, pseudogeneRNU6-930P